156 related articles for article (PubMed ID: 29949791)
1. LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.
Chen S; Wang LL; Sun KX; Liu Y; Guan X; Zong ZH; Zhao Y
Cell Physiol Biochem; 2018; 47(4):1578-1588. PubMed ID: 29949791
[TBL] [Abstract][Full Text] [Related]
2. Role of the lncRNA ABHD11-AS
Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y
Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073
[TBL] [Abstract][Full Text] [Related]
3. MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a.
Zhang S; Li Z; Zhang L; Xu Z
Mol Med Rep; 2018 Jul; 18(1):202-208. PubMed ID: 29749452
[TBL] [Abstract][Full Text] [Related]
4. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma.
Li Q; Shen F; Zhao L
Biomed Pharmacother; 2018 Nov; 107():918-928. PubMed ID: 30257404
[TBL] [Abstract][Full Text] [Related]
5. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
7. PCGEM1 stimulates proliferation of osteoarthritic synoviocytes by acting as a sponge for miR-770.
Kang Y; Song J; Kim D; Ahn C; Park S; Chun CH; Jin EJ
J Orthop Res; 2016 Mar; 34(3):412-8. PubMed ID: 26340084
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced LncRNA PCGEM1 promotes invasion and metastasis of gastric cancer through regulating SNAI1.
Zhang J; Jin HY; Wu Y; Zheng ZC; Guo S; Wang Y; Yang D; Meng XY; Xu X; Zhao Y
Clin Transl Oncol; 2019 Sep; 21(9):1142-1151. PubMed ID: 30690667
[TBL] [Abstract][Full Text] [Related]
9. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.
Chen S; Wang J; Gou WF; Xiu YL; Zheng HC; Zong ZH; Takano Y; Zhao Y
Int J Mol Sci; 2013 Dec; 14(12):24187-99. PubMed ID: 24351810
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
11. A long noncoding RNA connects c-Myc to tumor metabolism.
Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
[TBL] [Abstract][Full Text] [Related]
12. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
[TBL] [Abstract][Full Text] [Related]
13. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice.
Wang X; Jiang W; Kang J; Liu Q; Nie M
Oncol Rep; 2015 Aug; 34(2):891-9. PubMed ID: 26035556
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
16. The Correlation between YAP and RhoA Expression in Prostate and Ovarian Tumor Stroma.
Lee MJ; Kim D
Asian Pac J Cancer Prev; 2022 Jan; 23(1):281-285. PubMed ID: 35092398
[TBL] [Abstract][Full Text] [Related]
17. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.
Srikantan V; Zou Z; Petrovics G; Xu L; Augustus M; Davis L; Livezey JR; Connell T; Sesterhenn IA; Yoshino K; Buzard GS; Mostofi FK; McLeod DG; Moul JW; Srivastava S
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12216-21. PubMed ID: 11050243
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract][Full Text] [Related]
20. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.
Fu X; Ravindranath L; Tran N; Petrovics G; Srivastava S
DNA Cell Biol; 2006 Mar; 25(3):135-41. PubMed ID: 16569192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
